Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes

Background. Sofosbuvir-containing regimens have been approved for treatment of hepatitis C virus (HCV) infection in human immunodeficiency virus (HIV)-infected patients. We assessed the effect of treatment with sofosbuvir and ribavirin on patient-reported outcomes (PROs) in individuals with HIV/HCV...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Infect Dis
Auteurs principaux: Younossi, Zobair M., Stepanova, Maria, Sulkowski, Mark, Naggie, Susanna, Puoti, Massimo, Orkin, Chloe, Hunt, Sharon L.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2015
Sujets:
Major Articles and Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5007583/
https://ncbi.nlm.nih.gov/pubmed/25583164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiv005
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires